SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-16-465672
Filing Date
2016-02-16
Accepted
2016-02-16 17:16:08
Documents
2
Group Members
CHRISTOPHER A. WHITECLARKE B. FUTCHHCRP OVERFLOW FUND GP, LLCHEALTHCARE ROYALTY GP II, LLCHEALTHCARE ROYALTY MANAGEMENT, LLCHEALTHCARE ROYALTY PARTNERS II, L.P.MICHAEL G. CARTERMOLAG HEALTHCARE ROYALTY, LLCTODD C. DAVISVANDERBILT ACCOUNT MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d280261dsc13ga.htm SC 13G/A 187690
2 EX-99.A d280261dex99a.htm EX-99.A 12875
  Complete submission text file 0001193125-16-465672.txt   202812
Mailing Address 7 HAMILTON LANDING SUITE 100 NOVATO CA 94949
Business Address 7 HAMILTON LANDING SUITE 100 NOVATO CA 94949 415-408-6200
Raptor Pharmaceutical Corp (Subject) CIK: 0001070698 (see all company filings)

IRS No.: 860883978 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-60719 | Film No.: 161430229
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 ATLANTIC STREET SUITE 600 STAMFORD CT 06901
Business Address 300 ATLANTIC STREET SUITE 600 STAMFORD CT 06901 203.388.9080
HCRP OVERFLOW FUND, L.P./SERIES B (Filed by) CIK: 0001609240 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A